Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy

Open Access

Peer-reviewed

Research Article

Riva Kovjazin,

Affiliation Vaxil BioTherapeutics Ltd., Weizmann Science Park, Nes-Ziona, Israel
⨯
Galit Horn,

Affiliation Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel-Aviv, Israel
⨯
Nechama I. Smorodinsky,

Affiliations Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel-Aviv, Israel, The Alec and Myra Marmot Hybridoma Unit, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel-Aviv, Israel
⨯
Michael Y. Shapira,

Affiliation Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
⨯
Lior Carmon

* E-mail: lior.carmon@vaxilbio.com

Affiliation Vaxil BioTherapeutics Ltd., Weizmann Science Park, Nes-Ziona, Israel
⨯

Reader Comments (0)

Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Hybridomas
Is the Subject Area "Hybridomas" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.